| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.6 |